Advertisement

Topics

Latest "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018" News Stories

11:54 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018" found in our extensive news archives from over 250 global news sources.

More Information about Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018 on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018 for you to read. Along with our medical data and news we also list Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018 Clinical Trials, which are updated daily. BioPortfolio also has a large database of Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018 Companies for you to search.

Showing "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018" News Articles 1–25 of 39,000+

Tuesday 19th February 2019

Shield Therapeutics (STX) - Fortified for growth

Edison Investment Research - Pharmaceuticals & healthcare - Shield Therapeutics: Shield Therapeutics is focused on the development and commercialisation of Feraccru, a CHMP-approved oral formulation of iron positioned for the treatment of iron deficiency (ID) with or without anaemia. In 2018, out-licensing Feraccru to Norgine re-established an active salesforce in core EU5 territories and provided...


VirtualHealth Announces WellCare Health Plans is Now Live on Helios Care Management Platform

VirtualHealth, provider of the leading SaaS platform for care management and population health, today announced that WellCare Health Plans, Inc. (NYSE: WCG) is now live on its next generation Helios solution. Helios is the first comprehensive care management platform purpose-built t

BTS to play headline show at London’s Wembley Stadium during Love Yourself world tour – The Independent

BTS to play headline show at London's Wembley Stadium during Love Yourself world tour The IndependentBTS' Love Yourself world tour is coming to Wembley Stadium Official Charts CompanyBTS Announces “Love Yourself: Speak Yourself” Tour In Stadiums Around The World soompiBTS Wembley Stadium date confirmed for Speak Yourself tour Metro.co.ukBTS Announces Stadium Dates for ‘Love Yourself: Spe...


BTS’ Love Yourself world tour is coming to Wembley Stadium – Official Charts Company

BTS' Love Yourself world tour is coming to Wembley Stadium Official Charts CompanyBTS to play headline show at London's Wembley Stadium during Love Yourself world tour The IndependentBTS at Wembley Stadium: K-Pop boyband add new London date to world tour Evening StandardBTS Wembley Stadium date confirmed for Speak Yourself tour Metro.co.ukBTS Announces “Love Yourself: Speak Yourself” Tour ...

$ICPT this $872 PT is one for #biotech history book, from peak #NASH hysteria after FLINT. Despite this so-called Ph3 victory, stock now down ~75% from ATH, while company burned $1.6 billion along the way.pic.twitter.com/kgmXFXURg4

$ICPT this $872 PT is one for #biotech history book, from peak #NASH hysteria after FLINT. Despite this so-called Ph3 victory, stock now down ~75% from ATH, while company burned $1.6 billion along the way. pic.twitter.com/kgmXFXURg4

International Hemp Oil Company, Functional Remedies, Announces Major Expansion of Distribution Relationships in Key U.S. Markets

Only Vertically-Integrated Hemp Oil Company Expands to 48 States Functional Remedies, the only vertically-integrated manufacturer of whole-plant hemp oil products, announced a major expansion of its distribution networks in key U.S. markets. Functional Remedies signed five new agreements with natural retail broker networks to expand the distribu...

Pneumatic Vacuum Elevators, LLC Announces the Release of How-to Make Your House Handicap Accessible

Pneumatic Vacuum Elevators, LLC has published a comprehensive infographic entitled “How-to Make Your House Handicap Accessible” to provide information on how-to make a house handicap accessible. MIAMI (PRWEB) February 19, 2019 Pneumatic Vacuum Elevators, LLC has published a comprehensive infographic entitled “How-to Make Your House Handicap Accessible” to provide information on how-to mak...

Fresenius Kabi Announces Inductees to Blood Donation Hall of Fame

12 selfless individuals and families recognized for their commitment to saving lives Fresenius Kabi announced today it has inducted 12 people as the 2018 class of the Fresenius Kabi Blood Donation Hall of Fame, a nationwide program that recognizes and shares the unique stories of individuals from across the country who demonstrate commitment and passio...

The new liver epidemic. #NASH has replaced hepatitis C as the most important nonalcoholic #liverdisease. Biotech and pharma are racing to tap into this enormous market https://go.nature.com/2Ng659Y pic.twitter.com/VWXdpJYm5f

The new liver epidemic. #NASH has replaced hepatitis C as the most important nonalcoholic #liverdisease. Biotech and pharma are racing to tap into this enormous market https://go.nature.com/2Ng659Y  pic.twitter.com/VWXdpJYm5f

#LungCancer is the most commonly diagnosed type of #cancer with an estimated 2 million new cases in 2018.pic.twitter.com/wLGYAm0lqU

#LungCancer is the most commonly diagnosed type of #cancer with an estimated 2 million new cases in 2018. pic.twitter.com/wLGYAm0lqU

Pfizer Receives European Approval for ZIRABEV™ (bevacizumab), a Biosimilar to Avastin®*

Pfizer Inc. (NYSE: PFE) today announced the European Commission (EC) has approved ZIRABEV™ for the treatment of metastatic carcinoma of the colon or rectum, metastatic breast cancer, unresectable advanced, metastatic or recurrent non-small cell lung cancer (NSCLC), advanced and/or metastatic renal cell cancer and persistent, recurrent or metastatic carci...

Global Cytotoxic Drugs Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryThe global Cytotoxic Drugs market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, capacity and production, product specifications etc.Major ApplicationMajor TypeKey manufacturers are included based on manufactur...

Biocure Technology Corp Announces a MOU with the Government of Uzbekistan and Gold-Dream LLC to Build a Manufacturing Plant to Produce Biosimilars

Biocure Technology Corp. (CSE:CURE) (OTCQB:BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Inc. ("CURE") has entered into a Memorandum of Understanding with the Agency of Development of the Pharmaceutical Industry under the Ministry of Health, The Republic of Uzbekistan (herein after called "MHU") and Gold-Dream LLC (herein after cal...

MediPharm Labs Corp.: MediPharm Labs Announces Listing on Frankfurt Stock Exchange

TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) ("MediPharm") a leader in specialized, research-driven cannabis extraction, distillation, purif...

$MOR Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire https://www.morphosys.com/media-investors/media-center/simon-moroney-ceo-and-co-founder-of-morphosys-announces-his-intention …

$MOR Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire https://www.morphosys.com/media-investors/media-center/simon-moroney-ceo-and-co-founder-of-morphosys-announces-his-intention …

BriaCell to Present Clinical and Scientific Findings with New Insights at Key Oncology Conferences

BriaCell Therapeutics Corp. (TSX:BCT, OTCQB:BCTXF) (OTCQB:BCTXF) ("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, today announces it has been selected to present a poster at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium, held February 28–March 2, 2019, in San Francisco, California. The post BriaCell to ...

Global Amorphous Polyalphaolefin Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryThe global Amorphous Polyalphaolefin market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, capacity and production, product specifications etc.Major ApplicationMajor TypeKey manufacturers are included based on ...

CDA Announces New Endorsed Program for Student Loan Refinancing

CommonBond can help dentists save thousands on student loan debt SACRAMENTO, Calif. (PRWEB) February 19, 2019 The California Dental Association is pleased to announce CommonBond as a CDA Endorsed Program that offers competitive student loan refinancing as a new member benefit. Student loan debt is one of the largest financial hurdles a dentist may face. The average educational debt for all indeb...

Special Learning Supports Ethics in the Field of (Applied) Behavior Analysis for the Global Autism Community

Why is Ethics an important topic for the field of behavior analysis? The most recently published (and widely adopted) 2018 Autism prevalence rate by the Centers for Disease (CDC) estimates that 1 in 59 children in the U.S. are affected by Autism Spectrum Disorder. It is generally accepted that Applied Behavior Analysis (ABA), an evidence-based behavioral intervention is considered the "gold s...

Rite Aid and GNC Announce Extension of Partnership Through 2022

Rite Aid Corporation (NYSE: RAD), one of the nation’s leading drugstore chains, and GNC (NYSE: GNC), a leading global specialty retailer of health and wellness products, announced today an agreement which extends their partnership through 2022. Rite Aid and GNC have had an exclusive partnership in the chain drug channel since December 1998. This press rel...

VA Paid Thousands For Adviser Involved In Privatization Push To Commute From California To D.C. Over Three Month Period

Darin Selnick, a senior Veterans Affairs adviser, flew to Washington, D.C. from California for two weeks out of every month, at taxpayers' expense. Reports show that the costs for the six trips during the time period between Oct. 21, 2018, and Jan. 19, 2019 included: $3,885.60 for six round-trip flights in coach, $5,595.46 for 23 nights in hotels and $1,976 for meals. In other news, an army vetera...

Ex-Celgene CEO Bob Hugin makes a leap back into biotech, joining an embattled Allergan’s board $AGN https://endpts.com/ex-celgene-ceo-bob-hugin-makes-a-leap-back-into-biotech-joining-an-embattled-allergans-board/ …

Ex-Celgene CEO Bob Hugin makes a leap back into biotech, joining an embattled Allergan’s board $AGN https://endpts.com/ex-celgene-ceo-bob-hugin-makes-a-leap-back-into-biotech-joining-an-embattled-allergans-board/ …

$ASRT Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin

$ASRT Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin

$GMDA Announces Agreement with $EDIT to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells https://finance.yahoo.com/news/gamida-cell-announces-agreement-editas-133200124.html …

$GMDA Announces Agreement with $EDIT to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells https://finance.yahoo.com/news/gamida-cell-announces-agreement-editas-133200124.html …

$ABBV NDA Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis. Expects regulatory decision in Q3 2019 https://www.prnewswire.com/news-releases/abbvie-announces-new-drug-application-accepted-for-pri

$ABBV NDA Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis. Expects regulatory decision in Q3 2019 https://www.prnewswire.com/news-releases/abbvie-announces-new-drug-application-accepted-for-priority-review-by-us-fda-for-upadacitinib-for-treatment-of-moderate-to-severe-rheumatoid-arthritis-300797706.html …


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks